Introduction. Exposure to Asian sand dust (ASD) is associated with enhanced pulmonary morbidity and mortality, and the reporting of such cases has rapidly increased in East Asia since 2000. The purpose of the study was to assess chronic lung toxicity induced by ASD. Material and methods. A total of 174 ICR mice were randomly divided into 5 control and 17 exposure groups. Suspensions of low dose (0.2, 0.4 mg) and high dose (3.0 mg) of ASD particles in saline were intratracheally instilled into ICR mice, followed by sacrifice at 24 hours, 1 week, and 1, 2, 3 and 4 months after instillation. Paraffin sections of lung tissues were stained with hematoxylin and eosin and by immunohistochemistry to detect a-smooth muscle actin, collagen III, matrix metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinases-1 (TIMP-1), CD3, CD20, immunoglobulin G, interleukin-1b and inducible nitric oxide synthase. Results. A lung histological examination revealed similar patterns in the lesions of the groups treated with high (3.0 mg) or low dose (0.4 mg) of ASD. Acute inflammation was observed 24 h after treatment and subsided after 1 week; persistent granulomatous changes were observed at 2 months, focal lymphocytic infiltration at 3 months, and granuloma formation at 4 months. An increase in the size of granulomatous lesions was observed over time and was accompanied by collagen deposition in the lesions. The cytoplasm of macrophages in inflammatory lesions showed positive immunolabeling for MMP-9 at 24 h, 1 and 2 months after instillation of 3.0 mg of ASD. Positive immunolabeling for TIMP-1 was demonstrated in the cytoplasm of macrophages at 2 and 4 months after instillation of 3.0 mg of ASD. These findings suggest association between the expression of MMP-9 and TIMP-1 with the development of lung granulomatous lesions. Conclusions. These findings suggest that collagen deposition resulting from the altered regulation of extracellular matrix is associated with granuloma formation in the lungs of mice treated with ASD.
Introduction
Asian sand dust (ASD; known as Kosa aerosol) originating from the arid deserts of Mongolia and China causes severe air pollution annually in the Asia-Pacific area, including China, Korea, and Japan 1 [1] . Epide- www.fhc.viamedica.pl miological studies of ASD in humans have shown that exposure to ambient ASD particles is associated with an increase in pulmonary [2] [3] [4] [5] [6] and cardiovascular problems [2, 3, 7, 8] , and increased mortality in Korea [9] [10] [11] [12] and Taiwan [13] . The frequency and scale of dust events giving rise to ASD aerosols have increased rapidly in East Asia since 2000 [14] . Because of recent environmental changes such as desertification and global warming, human and animals are at increased risk of frequent exposure to ASD and the resultant adverse health effects of ASD on the respiratory system.
A previous study [15] reported that the major mineralogical component of ASD is silica (SiO 2 ). Occupational exposure to crystalline silica is associated with silicosis, lung cancer, pulmonary tuberculosis, and chronic obstructive pulmonary disease [16] . In addition, patients with silicosis often develop autoimmune diseases [17, 18] . It has been reported that experimental chronic exposure to crystalline silica caused granuloma formation [19] [20] [21] [22] [23] and/or fibrosis [24] in rats. In addition, granulomatous inflammation, which is characterized by the accumulation of epithelioid macrophages containing crystalline silica particles in the tracheobronchial lymph nodes, has been reported in rats exposed to crystalline silica [20, 25, 26] .
Previous studies on pulmonary toxicity caused by intratracheally instilled high doses of ASD demonstrated that the mineralogical components of ASD particles, free from chemical and biological pollutants, caused acute inflammatory changes in lung tissues [27] [28] [29] . Indeed, these chronic changes were similar to those observed in the silica exposure study: focal infiltration of lymphocytes with an accumulation of epithelioid macrophages and granuloma formation in the lung, and aggregation of macrophages containing particles in the tracheobronchial lymph nodes, 2 and 3 months after instillation. These findings suggested that precautions should be taken to minimize exposure to ASD. Additionally, more experimental studies using the inhalation method with lower doses of ASD to mimic the natural low-level exposure occurring during the Kosa event season should be conducted in the future.
The purpose of the current study was to describe the chronic lung toxicity induced by intratracheally instilled low doses of ASD in mice and to elucidate the pathomorphogenesis of granuloma formation.
Material and methods

Animals.
A total of 174 male ICR mice (5 or 6 weeks old) were obtained from CLEA JAPAN Inc. (Tokyo, Japan). Animals were fed a CE-2 diet purchased from CLEA JAPAN, and water was provided ad libitum. The mouse cages were housed at a temperature of about 25°C with 55-70% humidity. All animal experiments were performed according to the Tottori University guidelines for animal welfare (http://www.tottori-u.ac.jp/kouhou/kisokusyuu/reiki_honbun/u0950581001.html). Body weight changes were recorded weekly to assess general health.
Preparation of particle samples. CJ-2 particles, which are simulated ASD particles were used in this study. The CJ-2 particles were obtained from General Science Corporation (Tokyo, Japan). The particles were collected from the surface soil in the southwest part of the Tengger desert in north-central China where dust storms occur frequently [15] . The CJ-2 particles contain 28.0% Si, 5.9% Al, 5.3% Ca, 3.0% Fe, 1.7% K, and 1.6% Mg, and the mean diameter of the particles was approximately 0.03 mm ± 0.01 mm, according to the manufacturer's data sheet. The CJ-2 particles were hot-air sterilized at 300°C for 1 hour to remove toxic substances (microbiological substances as well as chemicals including nitrogen oxide and sulfur oxide) adhering to ASD. The sterilization temperature was determined in accordance with previous studies [27] . It has been reported that neither the chemical composition nor the shape of mineral particles changed even when heated to 700°C [30] .
Preparation of ASD suspensions. The sterilized particles were suspended in 0.05 mL of sterilized saline solution for instillation. The suspensions were deflocculated via ultrasonic disintegration for 3 minutes. Three doses (low doses: 0.2 and 0.4 mg; high dose: 3.0 mg) of the particles were chosen to determine dose effects on lung toxicity in mice. The maximum deposition of particles in the lung of a single mouse was calculated using tidal volume and breathing rate [27] . The maximum weekly deposition of suspended particulate matter (0.1 mg/m 3 ), as measured by the Japanese national air quality standard, was approximately 0.03 mg. The instillation doses (0.2, 0.4 and 3.0 mg) in the present study represent 6.6, 13.2 and 99 times that amount, respectively [28] . Control mice received 0.05 mL of a saline solution.
Study protocol. A total of 174 mice were randomly divided into 5 control and 17 exposure groups ( Table 1) . The mice were anesthetized by an intraperitoneal injection of sodium pentobarbital (5 mg/100 g body weight). The suspensions were agitated immediately before intratracheal instillation, and 0.05 mL of the suspension was instilled with an intratracheal cannula in each mouse. Each intratracheal instillation procedure took 3 seconds.
The animals in each group were euthanized by exsanguination under deep anesthesia induced by intraperitoneal injection of sodium pentobarbital at 24 hours, 1 week, and 1, 2, 3 and 4 months after instillation.
Pathological examination. Four mice from each control group and five to ten mice from each particle-treated group were used for pathological examination (Table 1) . On dissection, the trachea was immediately exposed and 0.5 mL www.fhc.viamedica.pl of 10% neutral-buffered formalin was instilled gently with the use of syringe via the tracheal cannula at low pressure; formalin injection was carried out within 15 min after death. Whole lungs were removed and fixed by immersion in 10% neutral-buffered formalin for 1 day. Then, the lung lobes were separated, and transverse sections from each lobe were made. These transverse sections and tracheobronchial lymph nodes were placed into embedding cassettes and fixed by immersion in 10% neutral-buffered formalin for 3 days. Formalin-fixed tissues of lungs and tracheobronchial lymph nodes were routinely processed and embedded in paraffin for histopathological and immunohistochemical examination. Sections approximately 3-μm thick were cut and stained with hematoxylin and eosin (H & E). Pathological evaluations were performed by 2 pathologists. The area of each granuloma was measured by using the polygon area measurement function of a microscope digital camera DP21 (Olympus, Tokyo, Japan). The number of granulomas in the lung of each mouse was determined.
Immunohistochemistry: polymer method. Paraffin-embedded sections of the lungs of mice treated with saline alone or with 3.0 mg of ASD particles were used for immunohistochemical detection of a-smooth muscle actin (a-SMA), collagen III, matrix metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinases-1 (TIMP-1), CD3 (T lymphocyte marker), CD20 (B lymphocyte marker), immunoglobulin G, interleukin-1b (IL-1b) and inducible nitric oxide synthase (iNOS). For antigen retrieval, the sections were placed in citrate buffer solution (pH 5.4) and microwaved for 20 minutes. Endogenous peroxidase activity was quenched with 3% H 2 O 2 for 30 minutes at room temperature. The slides were then blocked with 10% normal goat serum for one hour at room temperature. Thereafter, the sections were incubated in primary antibodies overnight at 4°C (anti-a-SMA, Dako, Glostrup, Denmark, 1:80 dilution; anti-collagen III, Cosmo Bio Co. Ltd, Tokyo, Japan, 1:20,000 dilution; anti-MMP-9, Bioss, Boston, USA, 1:200 dilution; anti-TIMP-1, Bioss, 1:100 dilution; anti-CD3, Dako, Glostrup, Denmark, 1:400 dilution; anti-CD20, Thermo Fisher Scientific, CA, USA, 1:500 dilution; anti-mouse immunoglobulins, Dako, 1:300 dilution; anti-IL-1b, Santa Cruz Biotechnology, CA, USA, 1:50 dilution; and anti-iNOS, Abcam, Cambridge, UK, 1:100 dilution). The primary antibodies were replaced with phosphate-buffered saline (PBS) in negative controls. After incubation with primary antibodies, the sections were placed in a solution containing a peroxidase-labeled polymer conjugated to secondary anti-mouse and -rabbit antibodies (EnVision + kit/HRP, Dako) for 30 min at RT temperature. The positive reactions resulted in brown staining with 3,3'-diaminobenzidine tetrahydrochloride (DAB, Wako, Osaka, Japan) as a chromogen, and the sections were counterstained with hematoxylin.
Statistical analysis. All data were expressed as the mean ± standard deviation. Statistical analysis of the histopathological changes was performed using a Student's t-test for two-group comparisons. For all comparisons, p values less than 5% (p < 0.05) were considered statistically significant.
Results
Gross findings of the lungs
At 3 and 4 months after instillation of 3.0 mg of ASD particles, the surface of the lungs was rough. In addition, multiple tiny whitish foci were observed in the parenchyma and surface of the lung. No significant changes were observed in the other treated groups.
Histopathology of the lungs
Histological sections from control animals instilled with saline showed normal bronchiolar and alveolar architectures at all times examined. In histological sections from animals instilled with ASD particles, the particles were observed in the lungs at all times examined in all treated groups. The number of coarse particles detected at low magnification (×4) in the lung was consistent throughout the different time points in each treated group. Fine particles were also observed throughout the lungs in each treated group. Furthermore, the multifocal Figure 1) . Inflammatory changes were observed around the particles; the intensity and frequency of the inflammation tended to increase with the amount of particles instilled (Supplementary Figure 1 ). There were no signs of infection in the lungs of any mice used in this study. At 24 hours after instillation, the thickening of the alveolar wall accompanied by acute inflammatory changes, such as the infiltration of neutrophils and macrophages into the alveoli and bronchoalveolar junction, was observed in all treated groups (Supplementary Figure 1A , B).
At 1 week after instillation, the size of inflammatory foci was similar to that observed in lungs taken at 24 hours after instillation (Supplementary Figure 1C, D) . The inflammatory foci were primarily composed of spindle-shaped to elongated cells, macrophages and a small number of neutrophils in all treated groups. Inflammatory foci containing a small number of macrophages were also observed in all treated groups.
At 1 month after instillation, the size of inflammatory foci observed in the lungs seemed to be smaller than those at 1 week after instillation (Supplementary Figure 1E, F) . Inflammatory foci were composed of macrophages and occasional multinucleated giant cells.
In addition to the inflammatory responses observed in the lungs at 1 month after instillation, lung changes were reported in 60% of mice treated with 3.0 mg of ASD, at 2 months after instillation. These included the infiltration of lymphocytes and foamy macrophages around the blood vessels and bronchioli. Small granulomas, which were nodular foci of tightly clustered epithelioid macrophages and occasional multinucleated giant cells, were observed in the lungs of 10% of mice treated with 0.4 mg and 60% of those treated with 3.0 mg of ASD, at 2 months after instillation (Supplementary Figure 1H , Table 2 ). Focal aggregations of macrophages containing fine particles without large particles were noted in the lungs of all treated groups of mice sacrificed at 2 to 4 months after instillation.
At 3 months after instillation of ASD, granulomatous lesions of various sizes and the infiltration of lymphocytes were observed in the 3.0 mg treated group. The number and size of granulomatous lesions increased over time from 2 to 3 months after instillation (Table 2) Table 2 ). Focal accumulation of large foamy macrophages (Supplementary Figure 2B) , necrotic cells with scattered fine particles ( Supplementary  Figure 2A) , neutrophils and epithelioid macrophages were occasionally observed; these findings were similar to those reported at 2 months after instillation in the group treated with 3.0 mg of ASD (Supplementary Figure 1H) . In addition, scattered plasma cells containing Russell bodies (mott cells) [31] were observed around bronchioles at 3 months after instillation in the group treated with 3.0 mg of ASD.
At 4 months after instillation in the 3.0 mg treated group, the size of the granulomatous lesions were larger than those observed at 3 months, although the number of granuloma per mouse was almost the same (Table 2) . Spindle-shaped cells appeared in the granulomatous lesions again and the volume of the interstitium of granulomatous lesions increased (Supplementary Figure 3A) . Granuloma formation was observed in 45% of mice treated with 0.4 mg Figure 1K , Table 2 ) and 100% of mice treated with 3.0 mg of the particles (Supplementary Figure 1L , Table 2 ). In addition, lymphoid hyperplasia of bronchus-associated lymphoid tissue (BALT) with aggregation of macrophages containing fine particles and mott cells was observed at 4 months after instillation in both high and low dose treated groups (Supplementary Figure 4A-C) .
Histopathology of the tracheobronchial lymph nodes
Histological sections of the tracheobronchial lymph nodes from control animals instilled with normal saline showed no significant changes at all time examined after treatment.
At 24 hours and 1 week after instillation, mild infiltration of neutrophils in the tracheobronchial lymph nodes was observed in all treated groups. At 1 month after instillation, macrophages containing fine particles were present in the marginal sinus of the tracheobronchial lymph nodes in the 3.0 mg treated group. At 2 months after instillation, macrophages containing fine particles were frequently observed in the entire area of the tracheobronchial lymph nodes in the 3.0 mg treated group. At 3 and 4 months after instillation, focal aggregations of macrophages containing fine particles were seen in the tracheobronchial lymph nodes in the 3.0 mg treated group. In the 0.4 mg treated group, macrophages that contained particles were present in the tracheobronchial lymph nodes at 4 months after instillation.
Immunohistochemical examination of the lungs
The results of the immunohistochemical examination of the lungs of mice exposed to ASD are presented in Table 3 and Figures 1-4. a-SMA Spindle-shaped to elongated cells in the inflammatory foci at 1 week and 4 months after 3.0 mg of ASD instillation showed positive immunolabeling for a-SMA (Supplementary Figure 3C) . Positive immunolabeling was not observed in inflammatory foci at the other time points examined.
Collagen III Fibrillar component in the interstitium of the granulomatous lesions at 4 months after treatment with 3.0 mg ASD showed positive immunolabeling for collagen III (Supplementary Figure 3D) .
MMP-9
The cytoplasm of macrophages in inflammatory lesions showed positive immunolabeling for MMP-9 at 24 hours ( Figure 1A ), 1 ( Figure 1C ) and 2 months ( Figure 1D ) after instillation of 3.0 mg of ASD. However, at 1 week ( Figure 1B ), 3 ( Figure 1E ) and 4 months ( Figure 1F ) after instillation of 3.0 mg of ASD, no positive staining for MMP-9 was observed in the granulomatous lesions.
TIMP-1
The cytoplasm of macrophages showed positive immunolabeling for TIMP-1 at 2 ( Figure 2D 
CD3 and CD20
At 2 months after treatment with 3.0 mg of ASD and at 3 months after treatment with 0.4 mg of ASD, Figure 2C) . Some scattered lymphocytes in the same lesions showed positive immunolabeling for CD20 (Supplementary Figure 2D) .
Immunoglobulin G
The cytoplasm of lymphocytes, accumulated around bronchioles at 4 months after treatment with 3.0 mg of ASD, showed positive immunolabeling for immunoglobulin G (Supplementary Figure 4D) .
Interleukin-1b (IL-1b)
The cytoplasm of macrophages in the inflammatory lesions at 24 hours after instillation of 3.0 mg of ASD showed positive immunolabeling for IL-1b ( Figure 3A) . Inflammatory lesions were negative for IL-1b at www.fhc.viamedica.pl
Discussion
Chronic pulmonary toxicity induced by intratracheal instillation of the mineral component of low doses (0.2, 0.4 mg) of ASD particles or a high dose (3.0 mg) of ASD particles, free from chemical and biological substances, was pathologically examined in this study. Both acute (examined at 24 hours and 1 week) or chronic (3 months and 4 months) pulmonary inflammatory changes in lungs exposed to low doses of ASD were evaluated. ASD caused acute inflammatory changes in the lung 24 hours after instillation. The changes were transient and subsided at 1 week following treatment. After this period, the lung lesions seemed to diminish; only minor foci were occasionally observed at 1 and 2 months after instillation. Exacerbation of inflammation, which is characterized by the infiltration of lymphocytes, was, however, occasionally www.fhc.viamedica.pl observed at 3 and 4 months. Multinucleated giant cells were also reported in the lung lesions at 2, 3, and 4 months following treatment. Small granuloma formation was observed in the lung lesions and scattered macrophages containing ASD particles were observed in the tracheobronchial lymph nodes at 4 months. These findings, including granuloma formation observed at low doses (0.4 mg), were qualitatively similar to those reported in previous high dose (3.0 mg) experiments [29] .
In the aforementioned previous study [29] , inflammatory responses to high doses of ASD were examined for up to 3 months after instillation; granulomatous lesions were observed at 2 and 3 months following treatment. In the present study, pathological examination during the longer period (4 months) was carried out in order to further elucidate the pathomorphogenesis of granulomatous lesions. The size of granulomatous lesions in mice treated with 3.0 mg ASD gradually increased in the period from www.fhc.viamedica.pl 2 to 4 months after instillation. These lesions were composed of inflammatory cells such as macrophages and lymphocytes at 2 months, and inflammatory cells including macrophages and spindle-shaped cells at 4 months along with an increase in the interstitium. The interstitial substance was positive for collagen III by immunohistochemistry, suggesting that the fibrotic event is associated with the development and enlargement of granulomatous lesions after instillation of ASD particles. Previous research [15] reported that the major mineralogical component of ASD is silica (SiO 2 ), which is derived mainly from feldspar and quartz (crystalline silica). Occupational exposure to crystalline silica leads to silicosis, which is characterized by a progressive granulomatous and fibrogenic response in the lung [21] . In experimental silicosis, the increase of collagen deposition in the lungs of rats over time has been reported [32] . Therefore, it is expected that the fibrotic response may progress and the size of granulomatous lesions become larger when observed at more advanced time points after instillation of a high dose of ASD.
The volume of the pulmonary extracellular matrix is, in part, regulated by matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs). MMPs play a central role in the regulation of multiple cellular functions such as cell proliferation, adhesion, migration, differentiation, angiogenesis, and apoptosis [33] and are capable of digesting extracellular matrix such as collagen and basement membrane components [34] and also acting as cell mediators. Because of its strong destructive ability, the activity of MMPs is strictly regulated by TIMPs [35] . TIMPs are also able to promote the proliferation of a variety of cells including fibroblasts [36] . Several pulmonary chronic diseases are proposed to result from the disturbance of the equilibrium between the synthesis and degradation of the pulmonary extracellular matrix; the activation of MMPs and TIMPs is involved in the process. Previous research has reported that the excessive or inappropriate expression of MMPs contributes to the pathogenesis of tissue destructive diseases such as pulmonary emphysema [37] . On the other hand, the development of pulmonary fibrosis is associated with an increase of TIMP-1 expression [38] . In addition, this increased expression of TIMP-1 appears to precede the increased accumulation of collagen [38] . The study reported here demonstrated the expression of MMP-9 in the acute inflammatory period and TIMP-1 in the chronic inflammatory period. Previously, the disruption of the basement membrane was observed in the lungs of mice treated with a high dose of ASD particles at 24 hours after instillation [28] . Expression of MMP-9 in the acute inflammatory lesions reported in this study may play a part in basement membrane disruption. Imbalance between MMP-9 and TIMP-1 was demonstrated in the lesions of acute pancreatitis [39] . As shown in experimental silicosis [40, 41] , increased TIMP-1 expression, decreased MMP-9 expression and deposition of collagen in the lesions were also observed at the chronic period in this study. These findings suggest the possible association of the imbalance of expression between MMP and TIMP with the development of granulomatous lesions in the lungs of mice treated with ASD.
The role of cytokines and oxidative stress markers, IL-1b and inducible iNOS, respectively, has been reported in studies investigating the pathogenesis of pulmonary toxicity induced by crystalline silica [42, 43] . Mice genetically deficient (knockout) in IL-1b or iNOS showed significantly reduced silicotic lesions [44] . The generation of IL-1b [43] and nitric oxide [44] was associated with the development of lung lesions including granuloma formation and fibrosis in experimental silicosis. In this study of ASD toxicity, IL-1b and iNOS expression were also demonstrated in both acute and chronic inflammatory lesions, suggesting that secondary released cytokines and oxidative stress generated in lesions may be involved in the development of the acute and chronic lung lesions induced by the intratracheally instilled ASD particles [45] .
Silicosis is characterized in part by elevations in serum and bronchoalveolar lavage immunoglobulins in silicosis patients [46, 47] and experimentally exposed animals [20] . Another well-known health outcome associated with silica exposure is an increase in the incidence of autoimmune disorders [48, 49] including rheumatoid arthritis [50] , scleroderma [51] , systemic lupus erythematosus [52] , and antineutrophilic cytoplasmic antibody-related nephritis [53] . Recent epidemiological studies on ASD have proposed that increased exposure to ASD particles is associated with the increased susceptibility to asthma, allergic rhinitis, contact dermatitis and conjunctivitis [1, 10, [54] [55] [56] [57] . The previous study of ASD instillation in mice [28] demonstrated lymphocytic infiltration, which is characterized by a mixed population of many T lymphocytes and some B lymphocytes, at 2 months after instillation of ASD particles. In this current study, many plasma cells containing Russell bodies (called mott cells) and the accumulation of immunoglobulin G-positive cells were observed at the peribronchial lesions of 0.4 and 3.0 mg treated mice at 4 months after instillation. In general, mott cells are regarded as plasma cells undergoing excessive synthesis of immunoglobulin and defective in secretion [31] www.fhc.viamedica.pl cells are rare in normal tissue but frequently encountered in lymphoid tissues of murine and human autoimmune diseases [58] and in chronic inflammatory lesions with hyper-activation of the immune system by pathogens [59] . Thus, the presence of plasma cells containing Russell bodies observed in the ASD treated mice in this study suggests that the activation of antibody-mediated immunity occurred in addition to cell-mediated immunity, which could be in a state of hyper-immunization.
Conclusions
This study demonstrated that the low (0.4 mg) and high (3.0 mg) dose of mineralogical components of ASD particles, free from chemical and biological pollutants, induced granulomatous lesions in lung tissues at 2 months after intratracheal instillation. The dose (0.4 mg) used in this study is similar to the volume of ASD particles that could have been inhaled on the seven consecutive days of the recorded highest concentration of suspended particulate matter (SPM, 0.898 mg/m 3 ) in ASD season in Japan. In addition, the size of the granulomatous lesions induced by the intratracheal instillation of a high (3.0 mg) dose of ASD gradually increased with collagen deposition over time. These findings suggest that ASD exposure has implications for public health. Since this study used the intratracheal instillation of ASD particles, with which is different from the atmospheric exposure of ASD in the natural environment, more experimental studies using the inhalation method with lower doses of ASD to mimic the natural low-level exposure occurring during the Kosa event season should be conducted in the future.
